<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02463487</url>
  </required_header>
  <id_info>
    <org_study_id>STU 092014-016</org_study_id>
    <nct_id>NCT02463487</nct_id>
  </id_info>
  <brief_title>Negative Pressure Wound Therapy as a Drug Delivery System</brief_title>
  <official_title>Negative Pressure Wound Therapy as a Drug Delivery System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Parkland Health and Hospital System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan a randomized clinical trial of 150 patients with infected&#xD;
      diabetes-related lower extremity wounds to compare the clinical and economic effectiveness of&#xD;
      negative pressure wound therapy with continuous irrigation and negative pressure wound&#xD;
      therapy without irrigation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will enroll 150 patients from two centers: The University of Texas&#xD;
      Southwestern University Hospital and Parkland Hospital. The investigators will screen and&#xD;
      enroll patients with wounds in the inpatient setting. Patients will be randomized to receive&#xD;
      traditional NPWT or NPWT with continuous irrigation while they are hospitalized. The average&#xD;
      hospitalization for patients that receive NPWT is 13.3 days. Patients that do not have their&#xD;
      wound surgically closed during hospitalization will be discharged with negative pressure&#xD;
      wound therapy for up to a total of four weeks of therapy. After discharge from the hospital,&#xD;
      subjects will be seen twice weekly by home health, and will be evaluated in clinic every 7&#xD;
      days (±7 days) up to a total of 16-week period or until 30 days after the wound heals.&#xD;
&#xD;
      Study Procedures:&#xD;
&#xD;
      Screening Procedures&#xD;
&#xD;
        -  Review and sign the Informed Consent and HIPAA Authorization&#xD;
&#xD;
        -  The study doctor will review the inclusion and exclusion criteria&#xD;
&#xD;
        -  Demographics (such as age, gender, race or ethnicity)&#xD;
&#xD;
        -  Physical exam&#xD;
&#xD;
        -  Sitting blood pressure and pulse&#xD;
&#xD;
        -  Height and weight&#xD;
&#xD;
        -  Collection of the medical and surgical history&#xD;
&#xD;
        -  Collection of the history of the wound&#xD;
&#xD;
        -  Wound assessment(s)/Debridement - various tests and measurements to assess the sensation&#xD;
           (feeling) and circulation (blood flow) in the subject's feet and lower legs. None of&#xD;
           these tests are invasive (using needles), uncomfortable or have risks greater than&#xD;
           standard care.&#xD;
&#xD;
        -  Wound imaging - photographs and images of the subject's wound using acetate tracings, a&#xD;
           digital camera and an ARANZ camera (a special type of camera that uses computer software&#xD;
           to calculate the volume of the wound)&#xD;
&#xD;
        -  Hyperspectral imaging&#xD;
&#xD;
        -  Vascular/Neurological evaluation&#xD;
&#xD;
        -  Results of standard-of-care laboratory tests including a white blood cell count, blood&#xD;
           chemistry (tests to see how well organs, such as the liver and kidneys are working), and&#xD;
           blood glucose. Results of a serum pregnancy test (standard care for women of&#xD;
           child-bearing potential as part of pre-op labs) will also be collected. About 2&#xD;
           tablespoons of blood will be drawn for these tests.&#xD;
&#xD;
        -  Collection of a list of the subject's current medications, including prescriptions,&#xD;
           over-the-counter medications, supplements and herbals.&#xD;
&#xD;
      This visit will last about 2 hours.&#xD;
&#xD;
      If the subject qualifies for the study, they will participate in the following procedures:&#xD;
&#xD;
      Group Assignment&#xD;
&#xD;
      If the researchers believe the subject can take part in this study, s/he will be assigned&#xD;
      randomly (like a flip of a coin) to receive one of the following therapies:&#xD;
&#xD;
        -  Negative Pressure Wound Therapy with Irrigation&#xD;
&#xD;
        -  Negative Pressure Wound Therapy without Irrigation&#xD;
&#xD;
      The group is assigned randomly (like flipping a coin). The sponsor or researchers do not know&#xD;
      in advance what group assignment each subject will receive. Neither the subject nor the&#xD;
      researchers will be allowed to choose which group s/he is assigned to.&#xD;
&#xD;
      Study Intervention&#xD;
&#xD;
      The subject will receive either:&#xD;
&#xD;
        -  Cardinal Pro +Simultaneous Irrigation (NPWTi) - Negative Pressure Wound Therapy with&#xD;
           Prontosan®, or&#xD;
&#xD;
        -  Cardinal Pro (NPWT) Therapy (without Prontosan®)&#xD;
&#xD;
      Assigned therapy will continue in the hospital until the physician determines that the wound&#xD;
      is ready for closure. If the subject's wound is healing, study therapy will be discontinued&#xD;
      and standard dressings will be applied. If surgical closure is needed, the subject will&#xD;
      return to the Operating Room for a procedure to close the wound.&#xD;
&#xD;
      If the wound is not ready for closure during the hospital stay, subjects will continue NPWT&#xD;
      at home for the remainder of the 4 weeks of treatment. NPWT at home will be without&#xD;
      irrigation (KCI VAC Via®).&#xD;
&#xD;
      Procedures and Evaluations during the Research The study therapy will only be given while the&#xD;
      subject is in the hospital. S/he will continue the therapy for up to 4 weeks or until the&#xD;
      wound is closed. Once the therapy is stopped s/he will continue to be followed by the study&#xD;
      doctor. After the subject is released from the hospital s/he will need to see the study&#xD;
      doctor Every 7 days (±7 days). If the subject's wound does not heal before 56 days after&#xD;
      his/her first surgery then s/he will no longer be taking part in the study. The study doctor&#xD;
      will continue to check the wound. If the wound closes, s/he will see the study doctor 30 days&#xD;
      later to have the closed wound checked.&#xD;
&#xD;
      12 Month Extension:&#xD;
&#xD;
      After the end of the defined study period, the patients will be followed observationally by&#xD;
      their electronic medical records for 12 months as it would not be feasible to ask them to&#xD;
      return for an in-person evaluation as: patients have moved, no longer have correct contact&#xD;
      information, as well as it would create a financial hardship on the patients to return for&#xD;
      further visits. In order to more appropriately determine long term results from&#xD;
      participation, a longer period of time of follow up is necessary. Related outcomes that we&#xD;
      would like to follow over a 12-month duration are incidence of new foot ulcerations,&#xD;
      re-ulceration of a previously healed foot wound, healing and time to healing of patients who&#xD;
      took longer than the current study allows, duration of antibiotics received for foot&#xD;
      infections, re-admissions to the hospital, need for subsequent surgery, amputation, loss of&#xD;
      limb, and death. This expanded follow up period would provide valuable information to the&#xD;
      long-term outcomes and complications of this high risk population and will help direct how&#xD;
      future efforts may be better focused to reduce complications and improve outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2, 2015</start_date>
  <completion_date type="Actual">August 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 28, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Who Achieved Complete Healing or Coverage of the Study Wound</measure>
    <time_frame>16 weeks</time_frame>
    <description>How many wounds fully healed in 16 weeks. Healing defined as fully epithelialized skin with no drainage.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Adverse Events of Participants</measure>
    <time_frame>16 Weeks</time_frame>
    <description>Total number of adverse events, including new foot ulcer formation, all-cause hospital readmission, and foot-related hospital readmission.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Wound Dehiscence After Hospital Discharge</measure>
    <time_frame>16 weeks</time_frame>
    <description>Dehiscence is defined as any part of a surgically closed wound that failed to heal when sutures were removed.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Diabetic Foot Ulcers</condition>
  <arm_group>
    <arm_group_label>Cardinal Pro + Irrigation (NPWTi)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Negative Pressure Wound Therapy with Irrigation: Quantum™ +Simultaneous Irrigation (NPWTi) - Negative Pressure Wound Therapy with Prontosan® Intervention is receiving the Cardinal Vac with Irrigation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cardinal Pro (NPWT) Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Negative Pressure Wound Therapy without Irrigation: Quantum™ (NPWT) -Negative Pressure Wound Therapy (without Prontosan®) Intervention is receiving the Cardinal Vac without Irrigation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardinal Pro +Simultaneous Irrigation (NPWTi)</intervention_name>
    <description>NPWT with low volume irrigation (15 cc/hr) with 1% polyhexanide biguanide (PHMB), Prontosan®</description>
    <arm_group_label>Cardinal Pro + Irrigation (NPWTi)</arm_group_label>
    <other_name>• Negative Pressure Wound Therapy with Irrigation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardinal Pro (NPWT) Therapy</intervention_name>
    <description>NPWT 125 mm Hg continuous pressure with foam interface</description>
    <arm_group_label>Cardinal Pro (NPWT) Therapy</arm_group_label>
    <other_name>• Negative Pressure Wound Therapy without Irrigation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Diagnosis of diabetes mellitus Men/women ≥21 years old Foot or ankle wounds sized 5 cm2&#xD;
        -100 cm2 ABI≥0.5 or toe pressures &gt;30 mmHg&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Active Charcot arthropathy Unable to use NPWT at home Untreated bone or soft tissue&#xD;
        infection Unable to keep research appointments Active alcohol or substance abuse&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lawrence A Lavery, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>UT Southwestern Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UT Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>April 16, 2015</study_first_submitted>
  <study_first_submitted_qc>June 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2015</study_first_posted>
  <results_first_submitted>July 24, 2020</results_first_submitted>
  <results_first_submitted_qc>August 12, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 14, 2020</results_first_posted>
  <last_update_submitted>August 12, 2020</last_update_submitted>
  <last_update_submitted_qc>August 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Larry Lavery</investigator_full_name>
    <investigator_title>Professor, Department of Plastic Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 25, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/87/NCT02463487/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study population was comprised of patients who were admitted to hospital with a moderate or severe foot infection that required incision and drainage and parenteral antibiotics and for whom negative pressure wound therapy (NPWT) was indicated. Patients who fit the criteria for the study were then recruited.</recruitment_details>
      <pre_assignment_details>The patients underwent a screening exam including&#xD;
evaluating sensory neuropathy with loss of protective sensation with a 10-gram monofilament&#xD;
Vibration Perception Threshold Testing&#xD;
ABI - ankle brachial index&#xD;
SPP - skin perfusion pressure&#xD;
Peripheral arterial disease (PAD) was defined as either ABI &lt;0.9 or SPP &lt;30 mm Hg.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Cardinal Pro + Irrigation (NPWTi)</title>
          <description>Negative Pressure Wound Therapy with Irrigation: Quantum™ +Simultaneous Irrigation (NPWTi) - Negative Pressure Wound Therapy with Prontosan® Intervention is receiving the Cardinal Vac with Irrigation&#xD;
Cardinal Pro +Simultaneous Irrigation (NPWTi): NPWT with low volume irrigation (15 cc/hr) with 1% polyhexanide biguanide (PHMB), Prontosan®</description>
        </group>
        <group group_id="P2">
          <title>Cardinal Pro (NPWT) Therapy</title>
          <description>Negative Pressure Wound Therapy without Irrigation: Quantum™ (NPWT) -Negative Pressure Wound Therapy (without Prontosan®) Intervention is receiving the Cardinal Vac without Irrigation&#xD;
Cardinal Pro (NPWT) Therapy: NPWT 125 mm Hg continuous pressure with foam interface</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
                <participants group_id="P2" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="65"/>
                <participants group_id="P2" count="65"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cardinal Pro (NPWT) Therapy</title>
          <description>Negative Pressure Wound Therapy without Irrigation: Quantum™ (NPWT) -Negative Pressure Wound Therapy (without Prontosan®) Intervention is receiving the Cardinal Vac without Irrigation&#xD;
Cardinal Pro (NPWT) Therapy: NPWT 125 mm Hg continuous pressure with foam interface</description>
        </group>
        <group group_id="B2">
          <title>Cardinal Pro + Irrigation (NPWTi)</title>
          <description>Negative Pressure Wound Therapy with Irrigation: Quantum™ +Simultaneous Irrigation (NPWTi) - Negative Pressure Wound Therapy with Prontosan® Intervention is receiving the Cardinal Vac with Irrigation&#xD;
Cardinal Pro +Simultaneous Irrigation (NPWTi): NPWT with low volume irrigation (15 cc/hr) with 1% polyhexanide biguanide (PHMB), Prontosan®</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="75"/>
            <count group_id="B2" value="75"/>
            <count group_id="B3" value="150"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.32" spread="8.22"/>
                    <measurement group_id="B2" value="49.07" spread="9.74"/>
                    <measurement group_id="B3" value="50.19" spread="9.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Achieved Complete Healing or Coverage of the Study Wound</title>
        <description>How many wounds fully healed in 16 weeks. Healing defined as fully epithelialized skin with no drainage.</description>
        <time_frame>16 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cardinal Pro (NPWT) Therapy</title>
            <description>Negative Pressure Wound Therapy without Irrigation: Quantum™ (NPWT) -Negative Pressure Wound Therapy (without Prontosan®) Intervention is receiving the Cardinal Vac without Irrigation&#xD;
Cardinal Pro (NPWT) Therapy: NPWT 125 mm Hg continuous pressure with foam interface</description>
          </group>
          <group group_id="O2">
            <title>Cardinal Pro + Irrigation (NPWTi)</title>
            <description>Negative Pressure Wound Therapy with Irrigation: Quantum™ +Simultaneous Irrigation (NPWTi) - Negative Pressure Wound Therapy with Prontosan® Intervention is receiving the Cardinal Vac with Irrigation&#xD;
Cardinal Pro +Simultaneous Irrigation (NPWTi): NPWT with low volume irrigation (15 cc/hr) with 1% polyhexanide biguanide (PHMB), Prontosan®</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Achieved Complete Healing or Coverage of the Study Wound</title>
          <description>How many wounds fully healed in 16 weeks. Healing defined as fully epithelialized skin with no drainage.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.87</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Adverse Events of Participants</title>
        <description>Total number of adverse events, including new foot ulcer formation, all-cause hospital readmission, and foot-related hospital readmission.</description>
        <time_frame>16 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cardinal Pro (NPWT) Therapy</title>
            <description>Negative Pressure Wound Therapy without Irrigation: Quantum™ (NPWT) -Negative Pressure Wound Therapy (without Prontosan®) Intervention is receiving the Cardinal Vac without Irrigation&#xD;
Cardinal Pro (NPWT) Therapy: NPWT 125 mm Hg continuous pressure with foam interface</description>
          </group>
          <group group_id="O2">
            <title>Cardinal Pro + Irrigation (NPWTi)</title>
            <description>Negative Pressure Wound Therapy with Irrigation: Quantum™ +Simultaneous Irrigation (NPWTi) - Negative Pressure Wound Therapy with Prontosan® Intervention is receiving the Cardinal Vac with Irrigation&#xD;
Cardinal Pro +Simultaneous Irrigation (NPWTi): NPWT with low volume irrigation (15 cc/hr) with 1% polyhexanide biguanide (PHMB), Prontosan®</description>
          </group>
        </group_list>
        <measure>
          <title>Total Adverse Events of Participants</title>
          <description>Total number of adverse events, including new foot ulcer formation, all-cause hospital readmission, and foot-related hospital readmission.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>New ulcer formation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All-cause readmission</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Foot-related readmission</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Wound Dehiscence After Hospital Discharge</title>
        <description>Dehiscence is defined as any part of a surgically closed wound that failed to heal when sutures were removed.</description>
        <time_frame>16 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cardinal Pro (NPWT) Therapy</title>
            <description>Negative Pressure Wound Therapy without Irrigation: Quantum™ (NPWT) -Negative Pressure Wound Therapy (without Prontosan®) Intervention is receiving the Cardinal Vac without Irrigation&#xD;
Cardinal Pro (NPWT) Therapy: NPWT 125 mm Hg continuous pressure with foam interface</description>
          </group>
          <group group_id="O2">
            <title>Cardinal Pro + Irrigation (NPWTi)</title>
            <description>Negative Pressure Wound Therapy with Irrigation: Quantum™ +Simultaneous Irrigation (NPWTi) - Negative Pressure Wound Therapy with Prontosan® Intervention is receiving the Cardinal Vac with Irrigation&#xD;
Cardinal Pro +Simultaneous Irrigation (NPWTi): NPWT with low volume irrigation (15 cc/hr) with 1% polyhexanide biguanide (PHMB), Prontosan®</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Wound Dehiscence After Hospital Discharge</title>
          <description>Dehiscence is defined as any part of a surgically closed wound that failed to heal when sutures were removed.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.08</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>16 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Cardinal Pro (NPWT) Therapy</title>
          <description>Negative Pressure Wound Therapy without Irrigation: Quantum™ (NPWT) -Negative Pressure Wound Therapy (without Prontosan®) Intervention is receiving the Cardinal Vac without Irrigation&#xD;
Cardinal Pro (NPWT) Therapy: NPWT 125 mm Hg continuous pressure with foam interface</description>
        </group>
        <group group_id="E2">
          <title>Cardinal Pro + Irrigation (NPWTi)</title>
          <description>Negative Pressure Wound Therapy with Irrigation: Quantum™ +Simultaneous Irrigation (NPWTi) - Negative Pressure Wound Therapy with Prontosan® Intervention is receiving the Cardinal Vac with Irrigation&#xD;
Cardinal Pro +Simultaneous Irrigation (NPWTi): NPWT with low volume irrigation (15 cc/hr) with 1% polyhexanide biguanide (PHMB), Prontosan®</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Foot-related hospital readmission</sub_title>
                <description>Readmission to the hospital after initial discharge for foot related infection</description>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>All-cause hospital readmission</sub_title>
                <description>Readmission to hospital for any reason after initial discharge</description>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="35" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Reinfection</sub_title>
                <description>Reinfection of the ulcer on the study foot</description>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>New ulcer formation</sub_title>
                <description>Formation of foot ulcer (different than the index ulcer) during the study</description>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lawrence Lavery, DPM, MPH</name_or_title>
      <organization>UT Southwestern Medical Center at Dallas</organization>
      <phone>214-645-0544</phone>
      <email>Larry.Lavery@UTSouthwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

